Comprehensive analysis of “basal like biomarkers” performed in a larger patient sample is mandatory thus to properly select basal like breast cancer cases and to further study the role of alternative hormone receptors in basal like breast cancer. This evidence concerns the gene NR4A1 and breast cancer.